Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Trends in Pharmacological Sciences|August 1, 1992
Designing therapeutically effective 5-lipoxygenase inhibitorsR M McMillan, E R WalkerBritish Journal of Pharmacology|January 1, 1990
2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activityS J Foster, P Bruneau, E R Walker, et al.British Journal of Pharmacology|December 1, 1992
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenaseR M McMillan, K E Spruce, G C Crawley, et al.Agents and Actions|September 1, 1991
Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase?K E Proudman, R M McMillanJournal of Medicinal Chemistry|July 10, 1992
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitorsG C Crawley, R I Dowell, P N Edwards, et al.Journal of Lipid Mediators|March 1, 1993
Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenaseG C Crawley, T G Bird, P Bruneau, et al.Agents and Actions|August 1, 1987
Leukotriene B4 metabolism in human leukocytes: fact or artefact?R M McMillan, S J Foster, P A DieppeThe Journal of Pharmacy and Pharmacology|March 1, 1979
Stimulation of human platelets by carrageenansR M McMillan, D E MacIntyre, J L GordonPageof 5